Company profile
Dxcover company profile
Dxcover is a clinical-stage liquid biopsy firm that is developing diagnostics for the early diagnosis of numerous malignancies, when treatment has a better possibility of having an influence on outcomes. The business was the first to use infrared spectroscopy of circulating pan-omic indicators to detect and identify cancer. The business has generated compelling clinical data on the diagnosis of Stage I and Stage II malignancies with high accuracy. Dxcover was established in 2016 in Glasgow, Glasgow City by David S Palmer, Holly Butler, and Matthew Baker.
Business identity
- Website
- http://www.dxcover.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $1M-$10M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Hollinwood, England, United Kingdom
- Postal code
- G1 1XW
- Country code
- GB
- Continent
- Europe